As Pearl Therapeutics’s new CEO, Mr Karsen brings more than 25 years of experience in the biotechnology and pharmaceutical industries.
Most recently, Mr Karsen served as regional president of Asia/Pacific and head of worldwide business development at Celgene, and was also a member of the company’s management, operating, and product development committees.
James Young, executive chairman of Pearl Therapeutics, said: “We are delighted to attract a corporate leader with such an outstanding record of achievement. The Pearl team has made exceptional progress on the development of its portfolio of novel products to treat respiratory diseases and we are confident that Perry, with his extensive background and experience, will contribute significantly to the further success of the company.”